More specifically, the role of galectin-3 as a mediator of pulmonary fibrosis has drawn attention since the inhibition of galectin-3 was found to decrease bleomycin-induced fibrosis and lung inflammation in mice [33]. This evidence concerns the gene LGALS3 and pulmonary fibrosis.